ABSTRACT
The purpose of this study is to describe active early rehabilitation in proximal phalanx fractures treated with rigid internal fixation. A total of 22 consecutive patients presenting with spiral, oblique or comminuted extra-articular fractures of the proximal phalanx were included in the study. All fractures were rigidly stabilized with plate and screws or screws alone and subsequently entered an active early rehabilitation programme. The mean follow-up period was 15.4 months (SD 10.1). Mean visual analogue scale pain score was 0.3 (SD 0.5) and Disability of the Arm, Shoulder and Hand score was 9.2 (SD 4.1). Mean total active motion was 241.9° (SD 18.3). According to the digital functional assessment, 86.3% of the patients had excellent results. Extension lags of the proximal interphalangeal joint were observed in seven fingers (mean lag, 3.4° (SD 5.5)). The results of this study demonstrated high patient satisfaction and good outcomes after the surgical technique and postoperative rehabilitation protocol described in open reduction and rigid internal fixation of proximal phalangeal fractures. LEVEL OF EVIDENCE: IV.
Subject(s)
Finger Injuries/rehabilitation , Finger Injuries/surgery , Finger Phalanges/injuries , Fracture Fixation, Internal , Fractures, Bone/rehabilitation , Fractures, Bone/surgery , Adolescent , Adult , Aged , Cohort Studies , Female , Humans , Male , Middle Aged , Range of Motion, Articular , Treatment Outcome , Young AdultABSTRACT
The aim of this study was to investigate the radiological and functional results of anatomical reduction and stable fixation followed by an early rehabilitation programme in the treatment of fractures of the base of the thumb metacarpal. Sixteen consecutive patients (11 men and five women; mean age: 36.4 years) with intra-articular fractures of the thumb metacarpal base were treated with plate and/or screw fixation between April 2002 and March 2011 at our department. Patients were followed-up for an average period of 15.62 months. Bony healing was achieved in all cases and all patients were able to return to pre-trauma activity levels 12 weeks following surgery. Open reduction with stable internal fixation and an early active rehabilitation programme appears to be an efficient method in the treatment of trapeziometacarpal joint fractures with satisfactory functional and radiological results.
Subject(s)
Finger Injuries/rehabilitation , Fracture Fixation, Internal/rehabilitation , Intra-Articular Fractures/rehabilitation , Metacarpal Bones/surgery , Thumb/surgery , Adolescent , Adult , Female , Finger Injuries/surgery , Humans , Intra-Articular Fractures/surgery , Male , Metacarpal Bones/injuries , Middle Aged , Recovery of Function , Retrospective Studies , Thumb/injuries , Young AdultSubject(s)
Carcinoma, Endometrioid/surgery , Carcinoma, Transitional Cell/pathology , Neoplasms, Multiple Primary/surgery , Ovarian Neoplasms/pathology , Uterine Neoplasms/surgery , Carcinoma, Endometrioid/pathology , Carcinoma, Transitional Cell/surgery , Female , Humans , Hysterectomy , Incidental Findings , Middle Aged , Neoplasms, Multiple Primary/diagnosis , Neoplasms, Multiple Primary/pathology , Ovarian Neoplasms/surgery , Ovariectomy , SalpingectomyABSTRACT
The aim of this study was to analyse low molecular weight heparin (LMWH) use during pregnancy in terms of patient evaluation, treatment indication and social and financial costs. This was a retrospective analysis of patients using LMWH in their pregnancies. A total of 147 women were included in the study. The most common indications were thrombophilia (55/147, 37.4%); recurrent pregnancy loss (RPL); (47/147, 32.0%) and previous single pregnancy loss (18/147, 12.2%). In the RPL group, 53.1% of patients were not evaluated with standard tests; 31.9% of women were incompletely evaluated and 15% were properly evaluated. Out of 104 women screened for thrombophilia, 32 (32/104, 30.8%) were tested during pregnancy. Despite published guidelines and increasing scientific evidence against their use in some indications, LMWHs are prescribed widely during pregnancy for a variety of indications. Public and healthcare providers' education to change this attitude should be implemented.
Subject(s)
Abortion, Spontaneous/prevention & control , Health Services Misuse , Heparin, Low-Molecular-Weight/therapeutic use , Pregnancy Complications, Hematologic/drug therapy , Thrombophilia/drug therapy , Adult , Female , Humans , Pregnancy , Retrospective Studies , Tertiary Care Centers/statistics & numerical data , Young AdultABSTRACT
Several authors have suggested that the final five weeks of gestation are a critical period for the development of the hip. In order to test the hypothesis that gestational age at birth may influence the development of the hip joint, we analysed the sonographic findings in 1992 hips (in 996 term newborns) with no risk factor for developmental dysplasia of the hip. The 996 infants were born at a mean gestational age of 39 weeks (37 to 41). The mean bony roof angle (α), cartilage roof angle (ß) and the distribution of the type of hip were compared between the 37th, 38th, 39th, 40th and 41st birth week groups. There was a significant difference in the distribution of type of hip between the different birth week groups (p < 0.001), but no significant difference between the α angles of all groups (p = 0.32). There was no correlation between birth week and roof angle (p = 0.407 and p = 0.291, respectively) and no significant correlation between birth weight and roof angle (p = 0.735 and p = 0.132, respectively). The maturity of the infant hip, as assessed sonographically, does not appear to be affected by gestational age, and the fetal development of the acetabular roof appears to plateau from 37 weeks.
Subject(s)
Gestational Age , Hip Dislocation, Congenital/diagnostic imaging , Hip Joint/diagnostic imaging , Mass Screening/methods , Female , Hip Joint/growth & development , Humans , Infant , Infant, Newborn , Male , Prospective Studies , Risk Factors , UltrasonographyABSTRACT
The objective of the study was to compare intracytoplasmic sperm injection (ICSI) outcome and gonadotropin doses between obese women with PCOS and non-obese patients with PCOS. This follow-up study represents ICSI outcomes in obese women with PCOS (BMIâ≥â30 kg/m(2)) compared with non-obese women with PCOS (BMIâ<â30 kg/m(2)). Obese (nâ=â18) and non-obese (nâ=â26) women with PCOS underwent long protocol pituitary suppression, ovarian stimulation and ICSI with fresh embryo transfer. Obese patients with PCOS required higher doses of gonadotropin (2994 IU vs 1719 IU; pâ<â0.001). Miscarriage rate was significantly higher in obese women compared with the non-obese women with PCOS (60% vs 6.7%, pâ=â0.002). Our results are valuable for counselling couples before initiation of assisted reproduction techniques (ART).
Subject(s)
Infertility, Female/therapy , Obesity/complications , Polycystic Ovary Syndrome/complications , Sperm Injections, Intracytoplasmic , Abortion, Spontaneous/epidemiology , Adult , Body Mass Index , Embryo Transfer , Female , Follicle Stimulating Hormone/administration & dosage , Humans , Infertility, Female/etiology , Live Birth , Pregnancy , Recombinant Proteins/administration & dosage , Treatment OutcomeABSTRACT
BACKGROUND: Total or cellular fibronectin (FN) determinations have been used to differentiate between normal and preeclamptic pregnants. The purpose of this study was to examine the relationship between maternal serum FN levels and the extracellular matrix molecule contents of placental tissue, such as FN, hyaluronic acid (HA) and hydroxyproline (HP) levels. MATERIAL AND METHODS: We obtained maternal blood samples and placental tissue samples from healthy (n = 17, controls) and preeclamptic pregnants (n = 29). We also obtained cord blood samples for FN and HA determination from the same patients. FN and HA concentrations in the placenta and maternal and cord blood were measured by and enzyme-linked immunosorbent assay and HP contents in the placenta were measured by a colorimetric assay. RESULTS: FN levels in maternal serum, cord blood, and placenta were significantly higher in preeclamptics than in controls (p<0.001, p<0.001 and p<0.05, respectively). HA concentrations in the cord blood and placenta were found to be elevated in preeclamptics (p<0.05 and p<0.01). Preeclamptics had significantly higher placental HP levels than controls (p<0.001). Similar statistically significant results were obtained when the pregnant subjects classified as nulliparous and multiparous. There was no difference in ECM molecule levels between nulliporous and multiparous women in preeclamptic pregnant group. In regression analysis maternal serum FN levels were correlated with placental HA and HP levels (p<0.01 and p<0.01). There was a positive correlation between cord blood FN and both placental HP (p<001) and HA levels (p<0.01). FN levels in maternal serum, cord blood, and placenta were also negative correlated with fetal birth weight (p<0.01, p<0.05 and p<0.05, respectively). CONCLUSION: FN in maternal serum, cord blood, and placenta is increased with elevated placental HA and HP levels, probably reflecting placental basement membrane alterations during preeclampsia.
Subject(s)
Fibronectins/blood , Hyaluronic Acid/metabolism , Hydroxyproline/metabolism , Placenta/metabolism , Pre-Eclampsia/blood , Adult , Case-Control Studies , Extracellular Matrix/metabolism , Female , Fetal Blood/metabolism , Humans , Pregnancy , Young AdultABSTRACT
OBJECTIVE: To assess whether alterations in the serum levels of placental growth factor, activin A and fibronectin could be detected in patients before they become preeclamptic. And to evaluate and compare the clinical utility of these markers and uterine artery Doppler velocimetry in predicting preeclampsia. METHODS: One hundred and twenty-two normotensive women were prospectively included in the study. Peripheral venous blood samples were obtained and Doppler examination of the uterine arteries was performed between 21 and 26 weeks' gestation. Serum levels of placental growth factor, activin A and fibronectin were measured by enzyme-linked immunoassay and radial immundiffusion technic. RESULTS: Mid-trimester maternal serum activin A and fibronectin levels and average S/D ratios were significantly higher whereas placental growth factor levels were significantly lower in women who subsequently developed preeclampsia than remained normotensive (p<0.001). The best cut-off values for predicting preeclampsia of placental growth factor, activin A and fibronectin based on ROC curve analysis were 90 pg/ml, 14 ng/ml and 370 mg/l respectively. The areas under the curve equal to 0.993, 0.972, 0.872 and 0.813 for placental growth factor, activin A, fibronectin and uterine artery Doppler respectively were determined for the prediction of preeclampsia. CONCLUSION: Placental growth factor, activin A, fibronectin and uterine artery Doppler are all potentially useful as predictors of preeclampsia. Maternal serum midtrimester PGF has the highest predictive value and activin A with a compatible accuracy for early identification of preeclampsia.
Subject(s)
Activins/blood , Fibronectins/blood , Inhibin-beta Subunits/blood , Pre-Eclampsia/diagnosis , Pregnancy Proteins/blood , Uterus/blood supply , Adult , Biomarkers/blood , Blood Flow Velocity , Female , Humans , Placenta Growth Factor , Pre-Eclampsia/blood , Predictive Value of Tests , Pregnancy , Pregnancy Trimester, Second , Prospective Studies , ROC Curve , Ultrasonography, Doppler, Color , Ultrasonography, Doppler, Pulsed , Uterus/diagnostic imagingABSTRACT
BACKGROUND: The aim of the study was to determine the best use of information obtained from Doppler studies of umbilical artery, thoracic aorta and middle cerebral artery in the management of pregnancies with growth restriction. METHODS: The study group consisted of 100 pregnant women with intrauterine growth restricted fetuses. Doppler flow velocity waveforms were obtained from the umbilical artery, middle cerebral artery and thoracic aorta. The pregnancies were grouped according to the umbilical artery Doppler results. There were 29, 30 and 41 fetuses with normal and high PI (pulsatility index), and absent end-diastolic velocity (AEDV) in the umbilical artery, respectively. RESULTS: Birth weight and umbilical vein pH at birth significantly decreased and perinatal mortality rates significantly increased with the worsening of the diastolic flow in the umbilical artery (p<0.01). Increased umbilical artery PI was significantly associated with increased thoracic aorta PI and decreased middle cerebral artery PI (r=0.75 and -0.55, p<0.01 respectively). Perinatal mortality due to fetal asphyxia in fetuses with AEDV in the umbilical artery and in both the umbilical artery and thoracic aorta was 39.5% and 50%, respectively. Detection of AEDV in the thoracic aorta was found to be the most significant predictive factor of perinatal deaths. CONCLUSIONS: The degree of abnormality of the Doppler findings parallels the severity of fetal compromise. Growth restricted fetuses with AEDV detected both in the umbilical artery and thoracic aorta are severely compromised and time gained in utero has no benefit for these fetuses.
Subject(s)
Aorta, Thoracic/diagnostic imaging , Fetal Growth Retardation/diagnostic imaging , Middle Cerebral Artery/diagnostic imaging , Ultrasonography, Doppler , Ultrasonography, Prenatal , Umbilical Arteries/diagnostic imaging , Adult , Birth Weight , Blood Flow Velocity , Female , Fetal Growth Retardation/physiopathology , Humans , Infant Mortality , Infant, Newborn , PregnancyABSTRACT
The combination of a thoracic cystic mass with vertebral anomalies on prenatal ultrasound suggests a neurenteric cyst. The outcome of such cysts mostly depends on the extent of the displacement and functional impairment of the adjacent organs and of the associated central nervous system defects. We present a case of a neurenteric cyst diagnosed on prenatal ultrasound at 34 weeks of gestation which was treated successfully in the early neonatal period.
Subject(s)
Neural Tube Defects/diagnostic imaging , Ultrasonography, Prenatal , Adult , Female , Fetal Diseases/diagnostic imaging , Humans , Infant, Newborn , Male , Neural Tube Defects/surgery , PregnancyABSTRACT
The aim of the study is to demonstrate the ability of abnormal Doppler indices to predict the acid-base status of the fetus. A pulsed Doppler study of umbilical artery, middle cerebral artery and thoracic aorta were assessed on 30 intrauterine growth restricted and 27 appropriate-for-gestational-age fetuses immediately before cordocentesis. All the fetuses with absent end diastolic velocity in the umbilical artery were found to be acidemic by cordocentesis. Thoracic aorta pulsatility index (PI) increased and middle cerebral artery PI decreased significantly with increased umbilical impedance (r = 0.702, r = -0.340, respectively). Umbilical artery and thoracic aorta PI significantly increased, whereas middle cerebral artery PI decreased with a decrease in umbilical blood pH (r = -0.760, r = -0.642, r = 0.292, respectively). Doppler findings have a very strong correlation with the acid-base status of the fetuses. Increased umbilical impedance is associated with progressive impairment of placental gas exchange and that by the time diastolic flow is lost hypoxaemia or acidaemia is usually present.